Physician profile
Joyce L Smith
NPI 1063957348
$3,199.97
in general payments reported to CMS, 2019-2025
7 companies · $2,821 in 2025
The $2,821 reported for 2025 was more than what 96% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $379 · 2025: $2,821.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,100 · Food and Beverage: $857 · Travel and Lodging: $243.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,100.00 |
| Food and Beverage | $857.30 |
| Travel and Lodging | $242.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $2,600.93 | 2025 | |
| Acadia Pharmaceuticals INC | $136.12 | 2024 | Nuplazid |
| Jazz Pharmaceuticals INC. | $124.45 | 2024 | |
| Amneal Pharmaceuticals LLC | $118.73 | 2024 | Crexont |
| Boehringer Ingelheim Pharmaceuticals, INC. | $114.64 | 2025 | Ofev |
| Abbvie INC. | $62.07 | 2025 | |
| Emd Serono, INC. | $43.03 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joyce Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.